MAPS Archives -

MDMA on track for 2023 approval as PTSD therapy, says developer

https://pharmaphorum.com/news/mdma-on-track-for-2023-approval-as-ptsd-therapy-says-developer/

Leadership: Cultivating a Culture of High Curiosity

https://pharmaphorum.com/partner-content-market-access/leadership-cultivating-a-culture-of-high-curiosity/

MAPS 2018 EMEA Annual Meeting

https://pharmaphorum.com/partner-content/events-partner-content/maps-2018-emea-annual-meeting/

Cementing the Value of Medical Affairs

https://pharmaphorum.com/views-analysis-sales-marketing/cementing-value-medical-affairs/

FDA names MDMA a ‘breakthrough’ for post-traumatic stress

https://pharmaphorum.com/news/fda-backs-late-stage-trial-mdma-post-traumatic-stress/

Medical Affairs – the heart of a data-driven, patient-centric pharma

https://pharmaphorum.com/views-and-analysis/medical-affairs-heart-data-driven-patient-centric-pharma/

Search